{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2869, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Data presented at Kymera R&D Day 2021. LLOQ = Lower Limit of Quantitation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/38", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "before_after", "function": "illustrate_case", "notes": "IRAK4 is stained red, DAPI is blue, and panCK (pan cytokeratin) is green.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/39", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data shows dose-dependent reduction in cytokine levels compared to placebo, correlated with IRAK4 degradation percentages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/40", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table details specific adverse events (Headache, Palpitations, Nausea) with subject counts, severity, and cohort distribution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/41", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "key_takeaways", "function": "summarize", "notes": "SAD = Single Ascending Dose; MAD = Multiple Ascending Dose; LLOQ = Lower Limit of Quantitation; HS = Hidradenitis Suppurativa; AD = Atopic Dermatitis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/42", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/43", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/44", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a hierarchical structure where three core pillars feed into an 'Expanding capabilities' foundation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/45", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "other", "function": "other", "notes": "The slide uses a grid layout to map drug assets against therapeutic areas (Dermatology, Respiratory, GI, Rheumatology, Hematology, Neurology, Oncology) and color-coded mechanisms of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/46", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow diagram to map biological signaling pathways from upstream initiation to downstream clinical manifestations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/47", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "propose_solution", "function": "present_solution", "notes": "Includes a biological pathway diagram and three charts demonstrating efficacy in inhibiting pNFkB, cytokines, and IRAK4 degradation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/48", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/49", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide illustrates a biological pathway diagram showing how IRAKiMiDs degrade both IRAK4 and IMiD substrates to inhibit proliferation and survival in cancer cells.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/50", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a structured layout to contrast patient numbers with clinical disease characteristics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/51", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-51", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Includes potency metrics (DC50, EC50) and dose-response curves for multiple cell lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/52", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-52", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Includes tumor volume growth curves and PK/PD degradation profiles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/53", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-53", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "before_after", "function": "analyze_data", "notes": "The slide demonstrates synergistic efficacy of KT-413 across three different combination therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/54", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-54", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "other", "function": "present_framework", "notes": "The diagram illustrates a multi-arm clinical trial design with dose escalation (DL1, DL2, DLx) leading to MTD/RP2D expansion cohorts for various indications, including combination therapy arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/55", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-55", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "roadmap", "function": "plan_implementation", "notes": "The diagram maps clinical trial inputs (left) to regulatory outcomes (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/56", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-56", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "key_messages", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/57", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-57", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/58", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-58", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a biological pathway diagram to explain the mechanism of action for a therapeutic target.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/59", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-59", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 60, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a central column to highlight patient numbers (US and ROW) for four specific disease indications, with clinical rationale on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/60", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-60", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 61, "slideType": "other", "function": "analyze_data", "notes": "The chart is a volcano plot, a common visualization in proteomics to show statistical significance vs. fold change.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/61", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-61", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 62, "slideType": "other", "function": "analyze_data", "notes": "The slide displays two line charts showing tumor volume over time for different dosing regimens.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/62", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-62", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 63, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes box plots for gene expression and tumor volume growth curves, plus a Kaplan-Meier survival curve.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/63", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-63", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 64, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow diagram to show the progression from initial dose levels (DL1, DL2, DLx) to expansion cohorts for various cancer types and combination therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/64", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-64", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 65, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process-flow diagram to map clinical trial phases to regulatory approval outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/65", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-65", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 66, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/66", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-66", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 67, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/67", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-67", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 68, "slideType": "other", "function": "establish_context", "notes": "The diagram illustrates a complex signaling loop involving STAT3, cytokines, and various cell types (leukocytes, endothelial, stromal) leading to disease states.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/68", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-68", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 69, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a structured table-like layout to map diseases to patient impact metrics and scientific evidence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/69", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-69", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 70, "slideType": "before_after", "function": "analyze_data", "notes": "The slide displays bar charts for fibrosis and bone growth, and line charts for clinical scores in arthritis and EAE models, alongside a summary table for the EAE model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/70", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-70", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 71, "slideType": "filler", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/71", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-71", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 72, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/72", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-72", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 73, "slideType": "other", "function": "present_framework", "notes": "The slide uses a three-column structure to define the selection process: Philosophy, Target Types, and Therapeutic Profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/73", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-73", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 74, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based grid to map specific assets (KT-474, KT-413, KT-253, KT-333) and future target pipelines against years 2021-2026.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/74", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-74", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 75, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/75", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-75", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 76, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The chart is a waterfall plot showing dependency scores across various cell lines, illustrating that p53-wildtype cells are highly dependent on MDM2.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/76", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-76", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 77, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a biological pathway diagram to contrast two therapeutic modalities (inhibitor vs. degrader) in the context of p53 regulation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/77", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-77", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 78, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a three-part process flow (degradation -> stabilization -> killing) supported by dose-response curves and a summary table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/78", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-78", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 79, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a biological mechanism diagram to explain the experimental results shown in the Western blots.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/79", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-79", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 80, "slideType": "before_after", "function": "analyze_data", "notes": "Shows that KT-253 (degrader) induces apoptosis even after short exposure, whereas DS-3032 (SMI) does not.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/80", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-80", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 81, "slideType": "before_after", "function": "analyze_data", "notes": "The slide compares tumor volume over time against biomarker expression levels (p53, p21, PUMA) following KT-253 administration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/81", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-81", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 82, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The left chart is a waterfall plot showing CRISPR sensitivity scores; the right chart is a dose-response curve comparing KT-253 and DS-3032.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/82", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-82", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 83, "slideType": "segmentation", "function": "present_framework", "notes": "Uses a Venn diagram to segment potential patient populations for MDM2 degradation therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/83", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-83", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 84, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/84", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-84", "loopMatches": [ { "to": 84, "from": 76, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "baf11c7b-bcf3-45f9-a0f0-de730275483d", "evidence": "The deck presents the limitations of current approaches and the benefits of Kymera's MDM2 degrader.", "position": 1, "objective": "To highlight the potential consequences of not adopting TPD, specifically in the context of MDM2 and p53.", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 85, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/85", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-85", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 86, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a visual metaphor of a 'wedge' expanding the druggable portion of the human proteome.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/86", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-86", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 87, "slideType": "propose_solution", "function": "present_solution", "notes": "Uses a three-column structure to categorize target classes and corresponding TPD solutions (Heterobifunctional Degraders, Molecular Glues).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/87", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-87", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 88, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a list-based structure to detail technical capabilities, with a sidebar legend explaining target types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/88", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-88", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 89, "slideType": "key_messages", "function": "analyze_data", "notes": "The chart uses dot size to represent abundance and color to represent different ligases/targets across tissue types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/89", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-89", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 90, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a dot plot to show expression profiles and molecular modeling to show ternary complex formation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/90", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-90", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 91, "slideType": "before_after", "function": "present_solution", "notes": "Shows Western blot data for E3 ligase expression and dose-response curves for POI degradation in cancer vs blood cells, plus in vivo viability comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/91", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-91", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 92, "slideType": "other", "function": "present_framework", "notes": "The slide uses a horizontal process-like layout to categorize different scientific screening techniques.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/92", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-92", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 93, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a process flow diagram for the fragment-based optimization and a heatmap for the covalent ligand screening.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/93", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-93", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 94, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table demonstrates a clear progression in optimization from Degrader 1 to Degrader 4, particularly in oral bioavailability (F%) across species.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/94", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-94", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 95, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow: MoA description -> Preclinical data (dog) -> Human prediction model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/95", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-95", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 96, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a visual comparison between 'Heterobifunctional Degraders' and 'Molecular Glues' to frame the technical approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/96", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-96", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-eb84-776b-8e7d-ce40a476afec", "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02", "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 97, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/97", "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec", "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-97", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }